Covered by insurance in all 50 states, incl. Medicare Advantage day one
Back to Blog

BuSpar vs Lexapro for Generalized Anxiety: Onset and Dosing

Clinically reviewed by Daniel Montville, MD

Reviewed October 21, 2026 · Last updated September 28, 2026

Key Takeaways

  • Neither BuSpar nor Lexapro is an as-needed medication: both were studied as scheduled daily treatments that lower the baseline of worry over weeks.
  • In pooled trials, Lexapro improved anxiety more than placebo starting at week 1 or 2, and buspirone improved some psychological anxiety symptoms by week 1 and all 14 symptom groups by week 4.
  • Canadian anxiety guidelines list escitalopram as a first-line treatment for generalized anxiety disorder and buspirone as a second-line option.
  • Lexapro carries more sexual side effects and discontinuation symptoms, while buspirone's most common early side effect is dizziness and it needs two or more doses a day.

When anxiety has been running your days for months, the first thing most people want is something that works right now. So it’s natural to ask whether BuSpar or Lexapro is the one to take when the worry spikes. The honest answer surprises a lot of people: neither one is built for that moment, and both are built for something steadier.

Generalized anxiety isn’t a single panic moment. It’s a baseline of worry and tension your nervous system carries day after day. The buspirone prescribing information describes a drug that binds strongly to 5-HT1A serotonin receptors and clears in 2 to 3 hours, while the Lexapro prescribing information describes an SSRI with a 27-to-32-hour half-life that reaches steady levels in about a week. Both aim to lower that baseline, and using either well takes precision about daily timing rather than the moment of a single dose.

For quick relief, benzodiazepines have long been the standard, and the evidence for their speed is solid. Canadian anxiety guidelines confirm their efficacy in generalized anxiety disorder but place them second-line, usually for short-term use, because of side effects, dependence, and withdrawal. The results are real, and the evidence is well established.

But fast relief isn’t the same as treating anxiety that lasts for months, and at Siggy we think you deserve a clear picture of what each daily option will and won’t do before you start. BuSpar and Lexapro are both scheduled medications that lower the baseline of worry over weeks, and neither is a controlled substance. They target the same generalized anxiety through different receptors, on different dosing schedules, with different trade-offs. The choice between them comes down to dosing, side effects, and evidence.

What This Page Covers

Why Neither One Works As-Needed

Buspirone is the one people most often try to take “when needed,” because it acts fast in the blood. The label says levels peak 40 to 90 minutes after a dose. Yet the trials behind it used scheduled daily dosing, starting at 7.5 mg twice a day, and the label notes it lacks the prominent sedative effect of typical anxiety medicines. A single dose during a spike usually feels like nothing.

Lexapro works on a longer clock. It’s taken once a day, morning or evening, and blood levels build for about a week before they settle. Its benefit depends on that steady level, so skipping days or taking it only on bad days works against it.

The shift in thinking is this: both medications turn down the volume on worry over weeks. If sudden surges are part of your anxiety, that’s a separate conversation with your prescriber.

BuSpar and Lexapro at a Glance

Here’s how the two compare, drawing on their FDA labels and the Canadian guidelines:

Feature BuSpar (Buspirone) Lexapro (Escitalopram)
Doses per day Two or more One
Half-life 2 to 3 hours 27 to 32 hours
Usual starting dose 7.5 mg twice daily 10 mg once daily
FDA use Anxiety disorders, studied in GAD GAD (age 7 and up), depression (age 12 and up)
Common early side effects Dizziness, nausea, headache Nausea, insomnia, sleepiness
Sexual side effects Infrequent Common
Guideline role in GAD Second-line First-line

Neither is a controlled substance. The buspirone label reports no evidence of tolerance or physical dependence, and Lexapro’s premarketing experience showed no drug-seeking behavior.

How Fast Each One Starts Working

The timelines are closer than many people expect. In a pooled escitalopram analysis of three trials with about 850 people, Lexapro improved anxiety significantly more than placebo beginning at week 1 or 2 and continuing through week 8. Those trials held the dose at 10 mg for the first 4 weeks, and people who stayed at 10 mg still did better than placebo.

For buspirone, a six-trial pooled analysis of 427 people found three groups of psychological anxiety symptoms improved by week 1. By week 2, 8 of 14 symptom groups had improved, and by the 4-week end point all 14 had improved compared with placebo.

The dosing schedule adds a difference. Lexapro usually starts at its target dose of 10 mg, with an increase to 20 mg allowed after at least a week. Buspirone starts at 15 mg a day and rises by 5 mg every 2 to 3 days, and trials commonly landed at 20 to 30 mg a day. With buspirone, your timeline often runs from when you reach a working dose rather than from your first pill.

A higher Lexapro dose isn’t automatically better. In a 12-week fixed-dose trial of 681 people, 20 mg wasn’t significantly more effective than 10 mg, and more people on 20 mg than on placebo dropped out because of side effects.

How Well Each One Works

Lexapro has the stronger evidence base in generalized anxiety. The Canadian guidelines list escitalopram, along with sertraline, paroxetine, duloxetine, and venlafaxine XR, as first-line treatments. They also report that in 6-to-18-month relapse-prevention trials of escitalopram, paroxetine, duloxetine, and venlafaxine XR, relapse rates were about 10% to 20% on medication, compared with 40% to 56% on placebo.

Buspirone works, but less consistently. A Cochrane review of 36 trials found buspirone and related drugs beat placebo, with about 4 to 5 people treated for one extra person to improve. The same guidelines call buspirone second-line, citing limited effectiveness in practice, and note it was less effective than venlafaxine XR in one trial and as effective as sertraline in another.

Scope matters too. The Canadian guidelines found buspirone didn’t work for panic disorder or social anxiety disorder, and the buspirone label reports two pediatric trials in 559 children and teens that showed no benefit over placebo. Lexapro is FDA-approved for generalized anxiety from age 7 and for depression from age 12, which helps when anxiety and depression overlap.

One more factor can make buspirone look weak. In a 735-patient analysis, people who had stopped a benzodiazepine within the past month improved less on buspirone and dropped out more often. People with no prior use or older use did about as well as with a benzodiazepine.

Side Effects and Stopping

The side effect profiles pull in opposite directions. In Lexapro’s generalized anxiety trials, nausea affected 18% of people versus 8% on placebo, and insomnia, sleepiness, fatigue, and lower libido were also more common. Ejaculation disorder affected 14% of men, and anorgasmia affected 6% of women. About 8% stopped because of side effects, versus 4% on placebo.

In buspirone’s pooled 4-week trials, dizziness affected 12% of people versus 3% on placebo, with nausea at 8% versus 5% and headache at 6% versus 3%. Drowsiness was about the same as placebo. The label lists libido changes as infrequent and delayed ejaculation as rare. Our guide to BuSpar side effects covers why dizziness often shows up first.

Stopping differs as well. The Lexapro label describes discontinuation symptoms such as dizziness, irritability, and electric shock sensations, and recommends a gradual taper. A 2024 meta-analysis listed escitalopram among the antidepressants with more frequent discontinuation symptoms. The buspirone label reports no evidence of physical dependence, but buspirone won’t cover withdrawal if you’re coming off a benzodiazepine.

Can You Take Them Together?

Sometimes, with monitoring. Both labels list buspirone among the serotonergic drugs that raise the risk of serotonin syndrome when taken with an SSRI, so the combination calls for monitoring, especially when starting or raising a dose.

Signs of serotonin syndrome can include agitation, a racing heart, sweating, fever, muscle stiffness, and diarrhea. If they appear, call 911.

Which One Fits Your Situation

These are considerations to talk through with your prescriber:

  • Lexapro may fit better if you want once-daily dosing, also have depression, or want the option with the strongest evidence for generalized anxiety.
  • BuSpar may fit better if SSRI sexual side effects are a dealbreaker, an SSRI didn’t agree with you, or you want to avoid SSRI discontinuation symptoms.
  • Either way, give it a fair trial. Most controlled trials ran 4 to 8 weeks, so judging either one after a few days is too soon.

Our guides to Lexapro for anxiety and how long BuSpar takes to work go deeper on each timeline.

If your anxiety is getting worse or you have thoughts of harming yourself, call or text 988. If you’re in immediate danger, call 911.

With both of these medications, the benefit builds gradually over weeks, which makes it easy to give up too early or push through side effects alone.

BuSpar and Lexapro both treat generalized anxiety as a daily medication rather than a rescue pill. Lexapro offers once-daily dosing and first-line evidence with more sexual and discontinuation side effects, while buspirone trades some effectiveness for a gentler profile and more doses a day. If you’re comparing other SSRIs too, our look at SSRI medications compared walks through the class.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical advice. Talk with your own clinician before starting, changing, or stopping any medication.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

Is BuSpar or Lexapro better for generalized anxiety?

For most people, Lexapro is the more established choice. Canadian guidelines list escitalopram as first-line for generalized anxiety disorder and buspirone as second-line. Buspirone still makes sense for some people, especially those who want to avoid SSRI sexual side effects or who didn't tolerate an SSRI.

Can I take BuSpar or Lexapro as needed for anxiety?

No. Both were studied as scheduled daily medications. Buspirone reaches peak blood levels within about 40 to 90 minutes, but its benefit builds over weeks of steady dosing. Lexapro takes about a week to reach steady levels. If you need help for sudden spikes of anxiety, ask your prescriber about that separately.

Which works faster, BuSpar or Lexapro?

They're similar. In pooled trials, Lexapro separated from placebo starting at week 1 or 2. Buspirone improved some psychological anxiety symptoms by week 1 and 8 of 14 anxiety symptom groups by week 2. Buspirone also needs several days of dose increases, while Lexapro usually starts at its target dose.

Does BuSpar cause sexual side effects like Lexapro?

Much less often. The buspirone label lists changes in libido as infrequent and delayed ejaculation as rare. In Lexapro's generalized anxiety trials, ejaculation disorder affected 14% of men, compared with 2% on placebo, and anorgasmia affected 6% of women, compared with less than 1%.

Can BuSpar and Lexapro be taken together?

Sometimes, under a prescriber's supervision. Both labels list buspirone among serotonergic drugs that raise the risk of serotonin syndrome when combined with an SSRI, so combined use calls for monitoring. Signs include agitation, a racing heart, fever, sweating, and muscle stiffness. Call 911 if they appear.

Why isn't BuSpar working for me?

It may need more time or a higher dose. Most people need at least a few weeks on a working dose, often 20 to 30 mg a day in divided doses. Recent benzodiazepine use can also blunt the response: people who stopped one within the past month improved less on buspirone in a 735-patient analysis.

Sources

  1. U.S. National Library of Medicine. Buspirone Hydrochloride Tablets Prescribing Information. Accord Healthcare Inc. DailyMed. dailymed.nlm.nih.gov
  2. U.S. National Library of Medicine. Lexapro (escitalopram) Tablets and Oral Solution Prescribing Information. DailyMed. dailymed.nlm.nih.gov
  3. Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14(Suppl 1):S1. doi:10.1186/1471-244X-14-S1-S1
  4. Goodman WK, Bose A, Wang Q. Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials. Journal of Affective Disorders. 2005;87(2-3):161-167. doi:10.1016/j.jad.2004.11.011
  5. Feighner JP, Cohn JB. Analysis of individual symptoms in generalized anxiety: a pooled, multistudy, double-blind evaluation of buspirone. Neuropsychobiology. 1989;21(3):124-130. doi:10.1159/000118565
  6. Baldwin DS, Huusom AKT, Maehlum E. Escitalopram and paroxetine in the treatment of generalised anxiety disorder: randomised, placebo-controlled, double-blind study. British Journal of Psychiatry. 2006;189:264-272. doi:10.1192/bjp.bp.105.012799
  7. Chessick CA, Allen MH, Thase M, et al. Azapirones for generalized anxiety disorder. Cochrane Database of Systematic Reviews. 2006;(3):CD006115. doi:10.1002/14651858.CD006115
  8. DeMartinis N, Rynn M, Rickels K, Mandos L. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder. Journal of Clinical Psychiatry. 2000;61(2):91-94. doi:10.4088/jcp.v61n0203
  9. Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The Lancet Psychiatry. 2024;11(7):526-535. doi:10.1016/S2215-0366(24)00133-0